Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Ocular Therapeutix Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
OCUL
Nasdaq
8731
https://www.ocutx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Ocular Therapeutix Inc
2 Small-Cap Growth Stocks With Room to Run
- Apr 24th, 2024 12:30 pm
Ocular Therapeutix Highlights Early Data From Diabetes-Related Eye Disorder
- Apr 18th, 2024 7:37 pm
Ocular Therapeutix™ Announces Positive Topline Phase 1 Data for AXPAXLI™ in Diabetic Retinopathy
- Apr 18th, 2024 11:00 am
The 3 Best Biotech Stocks to Buy Now: Q2 Edition
- Apr 16th, 2024 8:30 pm
Ocular Therapeutix™ Strengthens Clinical Team with Appointment of Key Retinal Leaders
- Apr 16th, 2024 11:00 am
Ocular Therapeutix™ Executive Chairman Pravin U. Dugel, MD Becomes President and CEO Antony Mattessich is Stepping Down as President and CEO
- Apr 15th, 2024 11:00 am
Down -17.88% in 4 Weeks, Here's Why Ocular Therapeutix (OCUL) Looks Ripe for a Turnaround
- Apr 9th, 2024 1:35 pm
Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Senior Vice President of Global Head of Biometrics
- Apr 9th, 2024 11:30 am
Ocular Therapeutix™ Announces Positive Phase 2 PAXTRAVA™ Glaucoma Data at the American Society of Cataract and Refractive Surgery 2024 Annual Meeting
- Apr 6th, 2024 2:00 pm
Million-Dollar Bets: 3 Under-$15 Stocks With Massive Potential
- Apr 1st, 2024 2:09 pm
Ocular Therapeutix™ To Present Data at the 2024 ASCRS Annual Meeting (American Society of Cataract and Refractive Surgery)
- Mar 26th, 2024 11:30 am
Q4 2023 Clearside Biomedical Inc Earnings Call
- Mar 13th, 2024 10:38 am
Wall Street Analysts Think Ocular Therapeutix (OCUL) Could Surge 34.74%: Read This Before Placing a Bet
- Mar 12th, 2024 1:55 pm
Ocular Therapeutix Inc Reports Growth Amidst Strategic Shifts
- Mar 11th, 2024 9:32 pm
Ocular Therapeutix (OCUL) Reports Q4 Loss, Misses Revenue Estimates
- Mar 11th, 2024 9:25 pm
Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2023 Results
- Mar 11th, 2024 8:05 pm
Ocular Therapeutix™ to Release Fourth Quarter and Full Year 2023 Results on March 11, 2024
- Mar 5th, 2024 12:30 pm
Criteo, Ocular Therapeutix, and More Stocks See Action From Activist Investors
- Mar 1st, 2024 11:30 pm
Should You Buy Ocular Therapeutix (OCUL) Ahead of Earnings?
- Feb 29th, 2024 1:52 pm
Are You Looking for a Top Momentum Pick? Why Ocular Therapeutix (OCUL) is a Great Choice
- Feb 26th, 2024 5:00 pm
Scroll